NEW YORK, January 23, 2013 /PRNewswire/ —

At the forefront of revolutionary medicine, Cannabis Science, Inc. (CBIS) [Full Research Report][1] has been heavily investing in the research and development of cannabis, otherwise known as marijuana. With focus on utilizing the medicinal use of marijuana, Cannabis Science is looking to bring medical treatments to areas such as cancer, PTSD and HIV. If the company achieves its goals, detractors may soon become supporters.

Debates on the use of marijuana have been growing despite its legalization in 18 states for medicinal purposes and 2 states for recreational use. While medical professionals continue to investigate and to further assess the benefits and risks of the drug, Cannabis Science is focused toward developing solutions within this new and ever expanding marketplace. Further driving the point home, Colorado recently granted recreational use of marijuana to its residents, a perfect fit for Cannabis Science’s current base of operations.

Remaining Conservative

Being in Colorado is an advantage for Cannabis Science to let its business take-off. However, choosing to maintain a controlled position in terms of developing a still controversial drug is probably the company’s smartest move. Although most Colorado residents would disagree, the executives of Cannabis Science may have already thought of the repercussions that may curb their business in the near future.

Finding cure for illnesses that are somewhat unheeded is the key to Cannabis Science’s future success. If the company decides to follow its current trajectory, their stance towards medicinal revolution may attract more investors. It may seem to be a gamble for some investors, but for those who have bolder minds and wish to invest in high reward ventures, Cannabis Science is an investment that may be the key to unlock the future of biotechnology and medicine.

Reference Links:

[1] The Full Research Report on Cannabis Science, Inc. – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/6b90_CBIS]

Consider National Traders Association

Tired of hearing about the latest, greatest trade opportunity… only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop — long before they become the next top news on major financial networks.

Contact: Demi Lapierre

Email: press@NationalTradersAssociation.org

Main: +1-(702)-212-4493